Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Outstanding 225.5% revenue growth YTD, positive net income, expanding EBITDA margins reaching 35%, strong cash flow and liquidity, combined with sustained technical momentum (+9% price gain) support NUTX as a hot idea despite ongoing legal risks requiring monitoring.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Margin Expansion ⢠Liquidity Strength ⢠Receivables Risk NUTX shows sharply improved quarterly profitability, liquidity, and leverage with lower valuation multiples, though high receivables, non-controlling interests, and negative retained earnings warrant caution.
Price Behavior
Key Price Behavior Insights: ⢠Strong Recent Rally ⢠Resistance Rejection ⢠Pullback Risk Support Level: $197â$200 (stronger: $188â$190) Resistance Level: $217â$218 NUTX remains bullish over the last month but faces active $217â$218 resistance, with a pullback risking a retest of $200â$197 support.
Sentiment & News
Key News Insights: ⢠Analyst Upside ⢠Momentum Strength ⢠Data Breach Nutex Health shows bullish analyst and momentum signals, tempered by ongoing cybersecurity scrutiny.
AI Summary
NUTX's investment case has shifted to proving that its exceptional June-quarter margins and cash flow are sustainable despite declining revenue and receivables equal to roughly 1.7x quarterly sales; investors should await evidence of revenue stabilization and collections quality before treating its low valuation as a durable bargain.
Description
Nutex Health, Inc. is a Houston-based, technology-enabled healthcare services company with two operating segments: a Hospital division that owns and operates 21 facilities across eight states, including micro-hospitals, specialty hospitals and hospital outpatient departments; and a Population Health Management division that manages provider networks and delivers management and administrative support to affiliated hospitals and physician groups. The population health unit also maintains a proprietary cloud platform that consolidates clinical and administrative data from multiple systems to provide a comprehensive view of patients and providers and to support care delivery.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Dec 31 | Jan 7 | NUTX | Nutex Health, Inc. | Outstanding 225.5% revenue growth YTD, positive net income, expanding EBITDA margins reaching 35%, strong cash flow and liquidity, combined with sustained technical momentum (+9% price gain) support NUTX as a hot idea despite ongoing legal risks requiring monitoring. | Closed | +8.2% |